Bjarnason GA. Can individualized sunitinib dose and schedule changes optimize outcomes for kidney cancer patients?. CUAJ [Internet]. 2016 Dec. 15 [cited 2024 Apr. 23];10(11-12):S252-5. Available from: https://cuaj.ca/index.php/journal/article/view/4293